GlassScriptPhysician profile
Jason Hu
NPI 1841332871
$911.35
in general payments reported to CMS, 2019-2025
13 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $216 · 2020: $218 · 2021: $72.07 · 2023: $24.73 · 2024: $244 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $405.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $380.66 | 2024-2025 | Reactiv8 |
| Pacira Therapeutics, INC. | $177.60 | 2019 | |
| Horizon Therapeutics Plc | $89.85 | 2020 | |
| Allergan, INC. | $87.65 | 2020-2021 | |
| Stryker Corporation | $49.55 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $24.73 | 2023 | Iovera |
| Depuy Synthes Sales INC. | $22.10 | 2019 | |
| Novo Nordisk INC | $18.54 | 2021 | |
| Pfizer INC. | $17.44 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.89 | 2021 | |
| Anika Therapeutics, INC. | $15.81 | 2019 | |
| Baudax Bio INC. | $11.53 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Hu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.